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Abstract
Background: Social Anxiety Disorder (SAD) is mainly characterized by an individual’s intense concern about other
people’s opinion of the individual. Notably, among those with severe anxious symptoms, we can often observe
self-referential feelings.
Objective: Faced with little research directed toward the exploration of psychotic symptoms in SAD patients, we
will approach the topic by describing three cases.
Discussion: Three explanations seem possible for the psychotic manifestations in SAD. The first one depends on
the individual’s ability or inability to challenge the impression of being criticized by people. A second possibility
would be the stressor and perpetuating role of SAD, which would make individuals more likely to present with
more severe mental disorders such as delusional disorder (DD). The third explanation would be the possibility that
SA is caused by a primary thought abnormality (psychotic self-reference) in some cases, instead of an affective
disturbance (anxious insecurity), which led to intense concern about others’ opinions. We also observed that
antipsychotics did not produce significant improvement in any of the three cases. This result may be related to
dopaminergic circuits and the D2 receptor hypoactivity.
Conclusion: The differentiation between delusion and anxious concern may be inaccurate and may change
throughout the disorder’s evolution. New diagnostic subcategories or the enlargement of the social anxiety
diagnostic is proposed to overcome the current diagnostic imprecision. There seems to be a symptomatic
spectrum between SAD and DDs.
Background
Social Anxiety Disorder (SAD) is mainly characterized
by an individual’s intense concern about other people’s
opinion of the individual. This concern frequently pro-
duces avoidance of and gradual divestment in social
relationships. The resulting reclusion produces a com-
mon diagnostic difficulty in distinguishing between SAD
and schizophrenia spectrum disorders, specifically clus-
ter A personality disorders.T od i s t i n g u i s hb e t w e e n
these disorders, clinicians usually evaluate the indivi-
dual’s interest in relationships, which is present in SAD,
whereas affective indifference is characteristic of schizo-
phreniform disorders. However, although these criteria
provide adequate method of distinguishing these disor-
ders in most cases, in some clinical situations, there is
interpenetration of these disorders.
So far, many studies have been dedicated to identify-
ing social anxiety (SA) symptoms in schizophrenic
patients. Among the most recent studies, given the fre-
quent relationship between these disorders observed in
the literature, Lysaker et al. [1] identified that negative
symptoms and self-stigma predicted SA symptoms. The
same authors [2], in another study, observed that greater
paranoia intensity correlated with stronger SA symp-
toms in schizophrenic patients, as indicated from their
better performances of mind theory (the ability to
understand others and one self’s mental states). In light
of these findings, the social relationships and affective
importance criteria seem to be weakened. This weaken-
ing is due to a wide variability in affective indifference
among schizophrenic patients, which is even wider
among individuals with cluster A personality disorders
or with higher affective preservation, like delusional
disorder (DD) patients. This indifference may not even
occur, or it can be inversely exacerbated, especially if
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any medium, provided the original work is properly cited.the patient is aware of his cognitive, affective and social
limitations.
Little investigation of psychotic symptoms in SAD
patients has been reported in the literature. Notably,
among those with severe anxious symptoms, we can
often observe self-referential feelings. Such feelings can
be accompanied by more or less criticism by the patient
of the symptom. The less insight the individual has that
this feeling is due to the patient’s thoughts, the closer
to delusion this symptom gets. As Martin and Penn [3]
have shown, in a nonclinical sample, greater paranoid
ideation is associated with higher levels of social
anxiety, avoidance, apprehension about evaluation,
self-observation and low self-esteem. An interesting
relationship between anxiety and psychosis was
observed by Freeman and Fowler [4]. These authors
found that a trauma history report influences the inten-
sity of persecutory thoughts through anxiety generation
and that anxiety is also responsible for the relationship
between substance use and paranoia.
Faced with little research directed toward the explora-
tion of psychotic symptoms in SAD patients, we will
approach the topic by describing three cases. These
cases were outpatients at an anxiety clinic linked to the
National Institute for Translational Medicine, Brazil [5].
Cases Presentation
Case 1 was a 30-year-old male, seeking treatment for
secondary use of smoked cocaine (crack). He had mod-
erate depressive symptoms and significant anxiety with
physical manifestations. His longitudinal history report
included intense nervousness, accompanied by palm
sweating, tachycardia and face flushing if exposed to
simple social interactions (e.g., requesting information
on the street or at work). Such events generated avoid-
ance behavior and produced failure in love relationships.
Crack use helped relieve those discomforts. These clini-
cal features led to a social phobia diagnosis, favoring
dependence on a cocaine derivative and a current
depressive episode. We started the patient on fluoxetine
(20 mg/day) and clonazepam (1.5 mg/day) and recom-
mended that he attend a support group and individual
psychotherapy. He remained abstinent for 60 days but
had a slight relapse afterward. During a second period
of abstinence, after about 45 days, he became increas-
ingly concerned about his neighbors’ opinion. He
believed that local youths, with whom he had previously
been involved in a physical fight in the context of narco-
tics consumption, mocked and teased him with the
intention of fighting again. He then became involved in
a fight in a commercial establishment near his house
after he felt provoked. He mentioned that one of the
individuals who “provoked” him entered the store and
asked aloud if the seller sold cigarettes. The patient
concluded that the question could only be a provocation
aimed at him, because smoking was not allowed at the
s i t e .T h u s ,b e f o r eh ed e f i a n t l y“lit a cigarette to cope
with him”, the patient started a discussion that culmi-
nated in a physical struggle. Soon after the event, the
patient relapsed on crack use. He sought psychiatric
treatment again, and only after the elucidation of his
symptoms did he express criticism of the self-referential
feeling and the delusional interpretation.
Case 2 was a 42-year-old male of Eastern descent. The
patient sought treatment for severe anxiety related to
going out alone on the street. In these situations, he had
the feeling that people would comment about him and
mock him. He also had an inability to maintain interper-
sonal relationships due to anxiety with symptoms such
as palpitations, tremor and sweating. The comments
and jeers that he feared referred to questions about his
sexual orientation. He also had dystonic neck move-
ment, which started after the temporary use of haloperi-
dol during a previous treatment and which worsened his
social anxiety. He was maintained using cloxazolam
(6 mg/day), which he was already taking, and was
started on fluoxetine (up to 40 mg/day). Despite the
reported reduction in psychological anxiety, the patient
did not improve his ability to establish social relation-
ships or reduce his concern about receiving negative
comments about his sexuality. In fact, these concerns
intensified, and he started to have a strong impression
that the neighbors and passers-by laughed when he
passed and made comments that indirectly questioned
his sexual orientation. Such feelings occurred only when
he walked alone on the street. He was convinced that he
was being harassed by the neighborhood, and he felt
very threatened. He started to interpret noises produced
in the vicinity of the house as provocations of him and
his father, with whom he lived. Faced with such intense
discomfort, he reported that it required great courage to
l e a v eh o m ea n d“face the world”.O no n eo c c a s i o n ,
when entering a supermarket, he was certain that he
had been cursed by an unknown person who sneezed by
h i ss i d e ,i n t e r p r e t i n gt h es o u n do ft h es n e e z ea st h e
word “queer.” Given these facts and the persistence of
tardive dystonia, he was started on quetiapine (50 mg/
day), scheduled for gradual dose adjustment according
to tolerability. Even with all the psychotic manifestations
described, the patient maintained his usual level of
function.
Case 3 was a 39-year-old female. She was referred to
psychiatric attention because of three months of depres-
sive symptoms, such as sadness and a lack of a will to
live. These symptoms were motivated by the belief,
which she had held for six months, that people loathed
and kept away from her because she exhaled a fetid
smell. She had the impression that people avoided or
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she could not find a reason for such conduct, she tried
to convince herself that it was a false impression. Never-
theless, she began to worry about her smell until, during
a family meeting, one of the cousins said the patient
was “stinking” and should stay away from him on the
picture. Since then, the patient believed that she had a
foul odor that, although she herself did not smell it, was
noticeable to others. Then, she started to wake up very
early to catch the first available public transportation,
avoiding further contact with people. When questioned
about the existence of anxiety symptoms throughout
life, she said she never talked to a classmate at school
and only four years ago could eat in the presence of
strangers, so she rarely ate during a workday due to
shame. The only intimate physical contact she allowed
was hugging her mother and sisters on their birthdays
and Christmas. Due to loss of appetite and intense
insomnia, she was started on amitriptyline (up to
125 mg/day) and diazepam (5 mg/day). The patient pre-
sented partial remission of the anxiety symptoms and
mood depression. She also used risperidone (up to
2 mg/day), which did not result in improvement and
worsened the conviction that she smelled bad. The anti-
psychotic was switched to haloperidol (3 mg/day). Then,
her delusional ideation improved. She showed extrapira-
midal symptoms and weight gain. The antidepressant
was switched to fluoxetine (up to 60 mg/day). Gabapen-
tine (900 mg/day) was added for therapeutic potentiat-
ing. The patient’s family reported that gabapentine was
the drug that most reduced the severity of the avoidant
behavior at home. In recent appointments, she has again
expressed the thought that everyone avoids her and the
conviction that the only possible reason is her smell.
Discussion
Three explanations seem possible for the psychotic
manifestations in SAD. The first one depends on the
individual’s ability or inability to challenge the impres-
sion of being criticized by people. This ability can lead
to two poles of symptoms:
1. The greater an individual’s ability to recognize that
the idea is exaggerated, the more the idea resembles an
anxious concern like an obsession. That finding is con-
sistent with a symptomatic presentation described in the
literature, which have similarities with the third case.
The olfactory reference syndrome [6] is characterized by
delusions that the individual exude a foul odor, although
it does not actually occur. The carriers of the disorder
tend to imagine that your breath, underarms and geni-
tals are with an unbearable stench for people lining with
them, taking them to isolation due to this belief. Due to
these delusions they also take several showers a day and
wash their clothes they wear obsessively. Hence this
disorder also be considered as part of the spectrum of
obsessive compulsive disorder.
2. The less insight, the greater the belief that the idea
is a reality, the more the experience resembles a delu-
sional self-reference. This delusion was present in the
first case in which the patient gradually developed a
conviction that he was harassed by the neighbors while
he repeatedly exposed himself to situations that rein-
forced this feeling. Later, when he challenged the delu-
sional idea and obtained some insight, he became able
to consider the absurdity of his thinking. The role of
use of derivatives of cocaine for the occurrence of psy-
chotic symptoms in the first case can not be neglected.
However, this element seems to be at best a partial
adjuvant. This can be affirmed because the patient had
symptoms while standing up for some months abstinent.
The relapse occurred because of the psychological
discomforts described. Although it is possible the pre-
sentation of psychosis later, the most common manifes-
tation is related to concomitant drug use or during the
withdrawal phase [7].
A second possibility would be the stressor and perpe-
tuating role of SAD, which would make individuals
more likely to present with more severe mental disor-
ders such as DD. This occurrence seems consistent with
the third case. The case’s evolution with delusion main-
tenance and poor response to antipsychotic treatment
may be considered to be usual paranoia. It seems as
though the second case also evolved with the occurrence
of DD, although its evolution and response to treatment
has not been observed. Michail and Birchwood [8] have
also raised this hypothesis by observing that psychotic
patients with SAD had more vivid feelings that “some-
o n eh a dt h ea i mt oh a r m ” them (45% vs. 11.6%) com-
pared with psychotic patients without SAD.
The third explanation would be the possibility that SA
is caused by a primary thought abnormality (psychotic
self-reference) in some cases, instead of an affective dis-
turbance (anxious insecurity), which led to intense con-
cern about others’ opinions. Faced with subsyndromal
manifestations, the clinical differentiation among these
conditions would be particularly difficult. Because of the
self-reference, interpersonal relationships would cause
particular concern and discomfort, thus causing the
individual to develop an avoidant personality. Despite
not belonging to cluster A, we suggest that the avoidant
personality of cases 2 and 3 could also be seen as a pre-
morbid functioning paranoia. This possibility is consis-
tent with that raised by Michail and Bischwood [8] that
“social anxiety and persecutory thinking develop concur-
rently in the early phase of psychosis and follow a simi-
lar course”.
The difficulty in distinguishing SA from psychosis in
some cases reveals the fragility of diagnostic constructs
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case’s particular situation, some authors [9] have
observed this presentation as an “offensive SAD sub-
type”, which also includes patients with (delusional)
conviction of offensiveness. Such concepts are the pro-
duct of a syndrome recognized in Japan since 1930 as
“Taijin-Kyofu” (TK) [10]. Its “conviction subtype” is
characterized by a strong belief and fear that others are
disturbed by the individual’s inadequacy. This inade-
quacy could occur in several ways due to the emission
of body odors, facial expressions, intestinal noises, and
so forth [9]. Among Western psychiatrists guided by the
DSM-IV, such a condition can only be diagnosed as a
DD. Still, TK has been described in some Anglo-Saxon
countries, such as Australia [11] and the U.S. [12]. In
view of this, we suggest that the “conviction subtype
TK” may represent a categorical model for patients
placed between SAD and the DDs at a spectral view.
We observed that antipsychotics did not produce sig-
nificant improvement in any of the three cases. This
result may be related to dopaminergic circuits and the
D2 receptor hypoactivity observed in SAD patients
[13,14]. Therefore, from the neuro-pathophysiologic
standpoint, it would make little sense to reduce the
function of a system already in deficit by blocking dopa-
mine’s action with an antipsychotic. It is important to
note that in the second case, typical antipsychotics wor-
sened the outcome due to the occurrence of tardive dys-
tonia. A series of case reports corroborate the lower
efficacy of using antipsychotics in SAD, even with the
occurrence of delusions. They observed better effective-
ness of selective serotonin and serotonin and norepi-
nefrine reuptake inhibitors on conviction-subtype TK
patients [12,15-18]. On the other hand, in the third case
reported, only risperidone was used as atypical agent.
Thus, despite the poor response to antipsychotics pre-
scribed, the condition can not be considered refractory,
once the prescription of other atypical antipsychotic
could generate satisfactory therapeutic response.
Conclusion
In this article, we observe the occurrence of psychotic
symptoms in patients with SAD. The differentiation
between delusion and anxious concern may be inaccu-
rate and may change throughout the disorder’se v o l u -
tion, as observed in the three cases described. Moreover,
t h er e s p o n s et oa n t i p s y c h o t i c sp r o v e dt ob ep o o r .T h e
addition of new diagnostic subcategories or the enlarge-
ment of the social anxiety diagnostic is proposed to
overcome the current diagnostic imprecision. There
seems to be a symptomatic spectrum between SAD and
DDs.
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